Sign In
Buy CME
$252.64
+2.11 (+0.84%)
At Close: Jun 03, 2026
Top Analyst Reports for Accenture, SAP & The Estee Lauder
04:35pm, Monday, 06'th Jun 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), SAP SE (SAP), and The Estee Lauder Companies Inc. (EL).
12 Analysts Have This to Say About CME Group
04:09pm, Friday, 03'rd Jun 2022 Benzinga
Over the past 3 months, 12 analysts have published their opinion on CME Group (NASDAQ:CME) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a compa
10 Biggest Price Target Changes For Friday
11:39am, Friday, 03'rd Jun 2022 Benzinga
BMO Capital cut Lululemon Athletica Inc. (NASDAQ: LULU) price target from $344 to $304. Lululemon shares fell 0.2% to $302.00 in pre-market trading.
Wells Fargo reduced RH (NYSE: RH) price target
2 Top Cryptocurrencies to Buy and Hold for Decades
03:47pm, Thursday, 02'nd Jun 2022 The Motley Fool
Bitcoin and Ethereum trade at attractive discounts to their all-time highs.
Why Is CME (CME) Down 12.8% Since Last Earnings Report?
05:32pm, Friday, 27'th May 2022 Zacks Investment Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is CME (CME) Down 12.8% Since Last Earnings Report?
03:04pm, Friday, 27'th May 2022
CME (CME) reported earnings 30 days ago. What's next for the stock?
CME Nears A Do-Or-Die Moment
10:26pm, Thursday, 26'th May 2022
CME was the perfect stock for monetary policy tightening and a commodity surge in the US economy; The stock peaked at $251 in late March '22 and has traded all the way down to its 200-week moving aver
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
02:13pm, Wednesday, 25'th May 2022 Benzinga
Upgrades
Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of
Here's Why Should You Stay Invested in CME Group (CME) Stock
01:56pm, Wednesday, 25'th May 2022 Zacks Investment Research
Compelling portfolio, driving higher clearing and transaction fees, as well as improving non-transactional revenues should continue to drive CME Group (CME).
Here's Why Should You Stay Invested in CME Group (CME) Stock
11:33am, Wednesday, 25'th May 2022
Compelling portfolio, driving higher clearing and transaction fees, as well as improving non-transactional revenues should continue to drive CME Group (CME).
What Does the Fed Interest Rate Hike Mean for CME Group?
03:04pm, Tuesday, 24'th May 2022 The Motley Fool
Rising interest rates are good for the financials of this company.
What Does the Fed Interest Rate Hike Mean for CME Group?
11:04am, Tuesday, 24'th May 2022
Rising interest rates are good for the financials of this company.
Crypto and Blockchain Get a Gut Check on Risk and Stability
07:45pm, Wednesday, 18'th May 2022 Zacks Investment Research
Risk management is not a science and still fully subject to the whims of human emotion and the madness of crowds.
Baron Fintech Fund Q1 2022 Shareholder Letter
04:55am, Wednesday, 18'th May 2022 Seeking Alpha
In the quarter ended March 31, 2022, Baron FinTech Fund (the “Fund”) fell 16.67% (Institutional Shares). Click here to read the full fund letter.
Analyst Ratings for CME Group
09:45pm, Monday, 16'th May 2022 Benzinga
Over the past 3 months, 11 analysts have published their opinion on CME Group (NASDAQ:CME) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a compa
